125 related articles for article (PubMed ID: 25985323)
1. DAX1 Overexpression in Pediatric Adrenocortical Tumors: A Synergic Role with SF1 in Tumorigenesis.
de Sousa GR; Soares IC; Faria AM; Domingues VB; Wakamatsu A; Lerario AM; Alves VA; Zerbini MC; Mendonca BB; Fragoso MC; Latronico AC; Almeida MQ
Horm Metab Res; 2015 Aug; 47(9):656-61. PubMed ID: 25985323
[TBL] [Abstract][Full Text] [Related]
2. Steroidogenic factor 1 overexpression and gene amplification are more frequent in adrenocortical tumors from children than from adults.
Almeida MQ; Soares IC; Ribeiro TC; Fragoso MC; Marins LV; Wakamatsu A; Ressio RA; Nishi MY; Jorge AA; Lerario AM; Alves VA; Mendonca BB; Latronico AC
J Clin Endocrinol Metab; 2010 Mar; 95(3):1458-62. PubMed ID: 20080844
[TBL] [Abstract][Full Text] [Related]
3. DAX1 gene expression upregulated by steroidogenic factor 1 in an adrenocortical carcinoma cell line.
Vilain E; Guo W; Zhang YH; McCabe ER
Biochem Mol Med; 1997 Jun; 61(1):1-8. PubMed ID: 9232190
[TBL] [Abstract][Full Text] [Related]
4. Transcription factors GATA-6, SF-1, and cell proliferation in human adrenocortical tumors.
Kiiveri S; Liu J; Arola J; Heikkilä P; Kuulasmaa T; Lehtonen E; Voutilainen R; Heikinheimo M
Mol Cell Endocrinol; 2005 Apr; 233(1-2):47-56. PubMed ID: 15767045
[TBL] [Abstract][Full Text] [Related]
5. DAX-1 expression in human adrenocortical neoplasms: implications for steroidogenesis.
Reincke M; Beuschlein F; Lalli E; Arlt W; Vay S; Sassone-Corsi P; Allolio B
J Clin Endocrinol Metab; 1998 Jul; 83(7):2597-600. PubMed ID: 9661652
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling of childhood adrenocortical tumors.
West AN; Neale GA; Pounds S; Figueredo BC; Rodriguez Galindo C; Pianovski MA; Oliveira Filho AG; Malkin D; Lalli E; Ribeiro R; Zambetti GP
Cancer Res; 2007 Jan; 67(2):600-8. PubMed ID: 17234769
[TBL] [Abstract][Full Text] [Related]
7. GATA6, SF1, NGFIB and DAX1 in the remodeled subcapsular zones in primary aldosteronism.
Nakamura Y; Kurotaki Y; Ise K; Felizola SJ; McNamara KM; Sasano H
Endocr J; 2014; 61(4):393-401. PubMed ID: 24531914
[TBL] [Abstract][Full Text] [Related]
8. Excess DAX1 leads to XY ovotesticular disorder of sex development (DSD) in mice by inhibiting steroidogenic factor-1 (SF1) activation of the testis enhancer of SRY-box-9 (Sox9).
Ludbrook LM; Bernard P; Bagheri-Fam S; Ryan J; Sekido R; Wilhelm D; Lovell-Badge R; Harley VR
Endocrinology; 2012 Apr; 153(4):1948-58. PubMed ID: 22294746
[TBL] [Abstract][Full Text] [Related]
9. Timing of adrenal regression controlled by synergistic interaction between Sf1 SUMOylation and Dax1.
Xing Y; Morohashi KI; Ingraham HA; Hammer GD
Development; 2017 Oct; 144(20):3798-3807. PubMed ID: 28893949
[TBL] [Abstract][Full Text] [Related]
10. Expression profiles of the glucose-dependent insulinotropic peptide receptor and LHCGR in sporadic adrenocortical tumors.
Costa MH; Latronico AC; Martin RM; Barbosa AS; Almeida MQ; Lotfi CF; Valassi HP; Nishi MY; Lucon AM; Siqueira SA; Zerbini MC; Carvalho LR; Mendonca BB; Fragoso MC
J Endocrinol; 2009 Feb; 200(2):167-75. PubMed ID: 18971217
[TBL] [Abstract][Full Text] [Related]
11. A novel stop-loss DAX1 variant affecting its protein-interaction with SF1 precedes the adrenal hypoplasia congenital with rare spontaneous precocious puberty and elevated hypothalamic-pituitary-gonadal/adrenal axis responses.
Yang H; Wei H; Shen L; Kumar C S; Chen Q; Chen Y; Kumar SA
Eur J Med Genet; 2021 May; 64(5):104192. PubMed ID: 33766795
[TBL] [Abstract][Full Text] [Related]
12. High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors.
Sbiera S; Schmull S; Assie G; Voelker HU; Kraus L; Beyer M; Ragazzon B; Beuschlein F; Willenberg HS; Hahner S; Saeger W; Bertherat J; Allolio B; Fassnacht M
J Clin Endocrinol Metab; 2010 Oct; 95(10):E161-71. PubMed ID: 20660055
[TBL] [Abstract][Full Text] [Related]
13. Characterization of differential gene expression in adrenocortical tumors harboring beta-catenin (CTNNB1) mutations.
Durand J; Lampron A; Mazzuco TL; Chapman A; Bourdeau I
J Clin Endocrinol Metab; 2011 Jul; 96(7):E1206-11. PubMed ID: 21565795
[TBL] [Abstract][Full Text] [Related]
14. Expression of steroidogenic factor 1 in canine cortisol-secreting adrenocortical tumors and normal adrenals.
Galac S; Kool MM; van den Berg MF; Mol JA; Kooistra HS
Domest Anim Endocrinol; 2014 Oct; 49():1-5. PubMed ID: 25010021
[TBL] [Abstract][Full Text] [Related]
15. Sonic hedgehog signaling is active in human adrenal cortex development and deregulated in adrenocortical tumors.
Gomes DC; Leal LF; Mermejo LM; Scrideli CA; Martinelli CE; Fragoso MC; Latronico AC; Tone LG; Tucci S; Yunes JA; Cardinalli IA; Mastellaro MJ; Brandalise SR; Ramalho F; Moreira AC; Ramalho LN; de Castro M; Antonini SR
J Clin Endocrinol Metab; 2014 Jul; 99(7):E1209-16. PubMed ID: 24712566
[TBL] [Abstract][Full Text] [Related]
16. Developmental Programming: Prenatal Testosterone Excess on Ovarian SF1/DAX1/FOXO3.
Puttabyatappa M; Matiller V; Stassi AF; Salvetti NR; Ortega HH; Padmanabhan V
Reprod Sci; 2020 Jan; 27(1):342-354. PubMed ID: 32046386
[TBL] [Abstract][Full Text] [Related]
17. Low DICER1 expression is associated with poor clinical outcome in adrenocortical carcinoma.
de Sousa GR; Ribeiro TC; Faria AM; Mariani BM; Lerario AM; Zerbini MC; Soares IC; Wakamatsu A; Alves VA; Mendonca BB; Fragoso MC; Latronico AC; Almeida MQ
Oncotarget; 2015 Sep; 6(26):22724-33. PubMed ID: 26087193
[TBL] [Abstract][Full Text] [Related]
18. Loss of growth hormone secretagogue receptor 1a and overexpression of type 1b receptor transcripts in human adrenocortical tumors.
Barzon L; Pacenti M; Masi G; Stefani AL; Fincati K; Palù G
Oncology; 2005; 68(4-6):414-21. PubMed ID: 16020971
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of DAX1 action.
Iyer AK; McCabe ER
Mol Genet Metab; 2004; 83(1-2):60-73. PubMed ID: 15464421
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the mTOR pathway in human normal adrenal and adrenocortical tumors.
De Martino MC; Feelders RA; de Herder WW; van Koetsveld PM; Dogan F; Janssen JA; Waaijers AM; Pivonello C; Lamberts SW; Colao A; de Krijger RR; Pivonello R; Hofland LJ
Endocr Relat Cancer; 2014 Aug; 21(4):601-13. PubMed ID: 24891456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
